Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 156.17M | 1.64 | $ 95.5M |
3/31/2025 | $ 126.88M | 1.13 | $ 112.59M |
12/31/2024 | $ 189.18M | 1.71 | $ 110.85M |
9/30/2024 | $ 120.5M | 1.14 | $ 105.68M |
6/30/2024 | $ 130.85M | 1.25 | $ 105.09M |
3/31/2024 | $ 171.98M | 1.76 | $ 97.91M |
12/31/2023 | $ 226.75M | 1.97 | $ 115.21M |
9/30/2023 | $ 168.03M | 1.83 | $ 91.95M |
6/30/2023 | $ 171.81M | 1.72 | $ 99.85M |
3/31/2023 | $ 294.15M | 2.85 | $ 103.38M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for INTELLIA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 179.75M ] / LiabilitesC [ $ 55.87M ]
(=) Cash Ratio [ 3.22 ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |